
Ambulatory oxygen significantly improved exercise performance in fibrotic interstitial lung disease (F‐ILD) patients, increasing walking distance by 37 meters (p=0.008) compared to placebo. Oxygen reduced desaturation, tachycardia, dyspnoea, and fatigue. The preference for oxygen over placebo was strong (2.6; p<0.0005), while oxygen was not significantly preferred over ambient air. These findings support the use of ambulatory oxygen and highlight the role of patient preferences.
Like
Save
Share